X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (676) 676
Publication (141) 141
Book Chapter (15) 15
Book Review (7) 7
Book / eBook (2) 2
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (332) 332
index medicus (248) 248
female (222) 222
rheumatology (193) 193
male (177) 177
aged (167) 167
middle aged (160) 160
osteoporosis (159) 159
risk factors (111) 111
article (109) 109
risk (83) 83
endocrinology & metabolism (73) 73
rheumatoid arthritis (70) 70
aged, 80 and over (69) 69
fractures (69) 69
adult (64) 64
united states (59) 59
abridged index medicus (57) 57
women (57) 57
postmenopausal women (56) 56
arthritis (51) 51
health aspects (51) 51
medicine & public health (51) 51
bone-mineral density (50) 50
drug therapy (50) 50
prevention (48) 48
arthritis, rheumatoid - drug therapy (47) 47
cohort studies (47) 47
care and treatment (46) 46
epidemiology (46) 46
therapy (46) 46
fracture (45) 45
research (44) 44
rheumatoid-arthritis (44) 44
double-blind (43) 43
medicine, general & internal (43) 43
management (42) 42
retrospective studies (42) 42
treatment outcome (42) 42
glucocorticoids - adverse effects (41) 41
united states - epidemiology (41) 41
bone density conservation agents - therapeutic use (39) 39
incidence (37) 37
medicare (37) 37
orthopedics (37) 37
osteoporosis - drug therapy (37) 37
gout (36) 36
mortality (35) 35
risk assessment (35) 35
alendronate (33) 33
bone density (31) 31
diphosphonates - therapeutic use (30) 30
internal medicine (30) 30
patients (30) 30
care (29) 29
diagnosis (29) 29
hip fracture (29) 29
prevalence (29) 29
analysis (28) 28
antirheumatic agents - therapeutic use (28) 28
osteoporosis - chemically induced (28) 28
united-states (28) 28
hyperuricemia (27) 27
osteoporosis - prevention & control (27) 27
pharmacology & pharmacy (27) 27
usage (27) 27
corticosteroids (26) 26
public, environmental & occupational health (26) 26
tumor necrosis factor-alpha - antagonists & inhibitors (26) 26
immunology (25) 25
safety (25) 25
bones (24) 24
comorbidity (24) 24
disease (24) 24
time factors (24) 24
bisphosphonates (23) 23
adherence (22) 22
clinical trials (22) 22
endocrinology (22) 22
glucocorticoids (22) 22
men (22) 22
studies (22) 22
vertebral fractures (22) 22
adolescent (21) 21
bone density - drug effects (21) 21
corticosteroid-induced osteoporosis (21) 21
cross-sectional studies (21) 21
dosage and administration (21) 21
double-blind method (21) 21
follow-up studies (21) 21
longitudinal studies (21) 21
risedronate (21) 21
surveys and questionnaires (21) 21
fractures, bone - prevention & control (20) 20
infliximab (20) 20
population (20) 20
age factors (19) 19
allopurinol (19) 19
anti-inflammatory agents, non-steroidal - adverse effects (19) 19
complications and side effects (19) 19
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arthritis & Rheumatology, ISSN 2326-5191, 05/2017, Volume 69, Issue 5, pp. 1122 - 1122
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 05/2017, Volume 69, Issue 5, p. 1122
Journal Article
Arthritis and Rheumatology, ISSN 2326-5191, 05/2017, Volume 69, Issue 5, p. 1122
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 05/2017, Volume 69, Issue 5, pp. 1122 - 1122
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 10/2016, Volume 68, Issue 10, pp. 2564 - 2564
Journal Article
Arthritis and Rheumatology, ISSN 2326-5191, 10/2016, Volume 68, Issue 10, p. 2564
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 10/2016, Volume 68, Issue 10, pp. 2564 - 2564
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 10/2016, Volume 68, Issue 10, p. 2564
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9671, pp. 1253 - 1263
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 15, pp. 1417 - 1427
Among postmenopausal women with osteoporosis and a high risk of fracture, treatment with the monoclonal antibody romosozumab for 12 months followed by... 
MEDICINE, GENERAL & INTERNAL | METAANALYSIS | BONE-MINERAL DENSITY | VERTEBRAL FRACTURES | DISEASE | AORTA | RANDOMIZED-TRIAL | RISK | STRENGTH | POSTMENOPAUSAL WOMEN | SCLEROSTEOSIS | Humans | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Risk | Bone Remodeling - drug effects | Alendronate - therapeutic use | Incidence | Spinal Fractures - prevention & control | Female | Drug Therapy, Combination | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - pharmacology | Alendronate - adverse effects | Bone Density - drug effects | Alendronate - pharmacology | Least-Squares Analysis | Aged | Cardiovascular Diseases - chemically induced | Fractures, Bone - prevention & control | Treatment outcome | Care and treatment | Fractures | Growth | Analysis | Monoclonal antibodies | Bones | Research | Jaw | Femur | Vertebrae | Immunoglobulins | Inhibitor drugs | Osteonecrosis | SOST protein | Bisphosphonates | Hip | Post-menopause | Bone resorption | Osteoporosis | Alendronic acid | Bone growth | Bone density | Drug therapy | Osteogenesis | randomized-trial | metaanalysis | disease | postmenopausal women | strength | bone-mineral density | Klinisk medicin | vertebral fractures | sclerosteosis | Clinical Medicine | aorta | risk | General & Internal Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2018, Volume 378, Issue 13, pp. 1200 - 1210
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 04/2006, Volume 8, Issue 1, pp. S2 - S2
Journal Article
Medical Care, ISSN 0025-7079, 3/2009, Volume 47, Issue 3, pp. 334 - 341
Introduction: Administrative claims data have a limited ability to identify persons with high compliance to oral bisphosphonates. We tested whether adding... 
Medication adherence | Osteoporosis | Prescription drugs | Antihypertensives | Diphosphonates | Securities and Exchange Commission regulation | Calcium channel blockers | Medications | Compliance certificates | Patient compliance | Adherence | Bisphosphonate | Compliance | DETERMINANTS | adherence | INSTRUMENTAL VARIABLES | PERSISTENCE | osteoporosis | ALENDRONATE | WOMEN | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | POSTMENOPAUSAL OSTEOPOROSIS | THERAPY | compliance | HEALTH CARE SCIENCES & SERVICES | bisphosphonate | HEALTH POLICY & SERVICES | HYPERTENSION | CLINICAL-PRACTICE | Medication Adherence - statistics & numerical data | Medication Adherence - psychology | Age Factors | United States | Humans | Insurance Claim Review | Middle Aged | Male | Osteoporosis - drug therapy | Diphosphonates - therapeutic use | Female | Chronic Disease - drug therapy | Hypoglycemic Agents - therapeutic use | Administration, Oral | Comorbidity | Bone Density Conservation Agents - therapeutic use | Insurance, Pharmaceutical Services | Logistic Models | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Preventive Health Services - utilization | Antihypertensive Agents - therapeutic use | Antidepressive Agents - therapeutic use | Sex Factors | Aged | Hypolipidemic Agents - therapeutic use
Journal Article